These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31662843)

  • 1. Rate of Progression in Activity and Participation Outcomes in Exercisers with Parkinson's Disease: A Five-Year Prospective Longitudinal Study.
    Miller SA; Mayol M; Moore ES; Heron A; Nicholos V; Ragano B
    Parkinsons Dis; 2019; 2019():5679187. PubMed ID: 31662843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of outcomes in exercisers with Parkinson disease: A two-year longitudinal cohort study.
    Combs-Miller SA; Moore ES
    NeuroRehabilitation; 2019; 44(3):425-432. PubMed ID: 31177244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical Functioning After 1, 3, and 5 Years of Exercise Among People With Parkinson's Disease: A Longitudinal Observational Study.
    States RA; Sweeny TL; Rossi A; Spierer DK; Salem Y
    J Geriatr Phys Ther; 2017; 40(3):127-134. PubMed ID: 27058217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regular Exercise, Quality of Life, and Mobility in Parkinson's Disease: A Longitudinal Analysis of National Parkinson Foundation Quality Improvement Initiative Data.
    Rafferty MR; Schmidt PN; Luo ST; Li K; Marras C; Davis TL; Guttman M; Cubillos F; Simuni T;
    J Parkinsons Dis; 2017; 7(1):193-202. PubMed ID: 27858719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Back to the basics: regular exercise matters in parkinson's disease: results from the National Parkinson Foundation QII registry study.
    Oguh O; Eisenstein A; Kwasny M; Simuni T
    Parkinsonism Relat Disord; 2014 Nov; 20(11):1221-5. PubMed ID: 25258329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiological complexity of gait between regular and non-exercisers with Parkinson's disease.
    Combs-Miller SA; Dugan EL; Beachy A; Derby BB; Hosinski AL; Robbins K
    Clin Biomech (Bristol, Avon); 2019 Aug; 68():23-28. PubMed ID: 31146080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-reported physical activity levels and clinical progression in early Parkinson's disease.
    Amara AW; Chahine L; Seedorff N; Caspell-Garcia CJ; Coffey C; Simuni T;
    Parkinsonism Relat Disord; 2019 Apr; 61():118-125. PubMed ID: 30554993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease Progression of Data-Driven Subtypes of Parkinson's Disease: 5-Year Longitudinal Study from the Early Parkinson's Disease Longitudinal Singapore (PALS) Cohort.
    Deng X; Saffari SE; Xiao B; Ng SYE; Chia N; Choi X; Heng DL; Ng E; Xu Z; Tay KY; Au WL; Tan EK; Tan LCS
    J Parkinsons Dis; 2024; 14(5):1051-1059. PubMed ID: 38848193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson's disease: a longitudinal cohort study and validation.
    Latourelle JC; Beste MT; Hadzi TC; Miller RE; Oppenheim JN; Valko MP; Wuest DM; Church BW; Khalil IG; Hayete B; Venuto CS
    Lancet Neurol; 2017 Nov; 16(11):908-916. PubMed ID: 28958801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifactorial assessment of Parkinson's disease course and outcomes using trajectory modeling in a multiethnic, multisite cohort - extension of the LONG-PD study.
    Chase BA; Krueger R; Pavelka L; Chung SJ; Aasly J; Dardiotis E; Premkumar AP; Schoneburg B; Kartha N; Aunaetitrakul N; Frigerio R; Maraganore D; Markopoulou K
    Front Aging Neurosci; 2023; 15():1240971. PubMed ID: 37842125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evolution of Parkinson's disease and prognostic factors affecting motor progression: 9-year follow-up study.
    Reinoso G; Allen JC; Au WL; Seah SH; Tay KY; Tan LC
    Eur J Neurol; 2015 Mar; 22(3):457-63. PubMed ID: 24888502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community-based high-intensity cycling improves disease symptoms in individuals with Parkinson's disease: A six-month pragmatic observational study.
    Rosenfeldt AB; Miller Koop M; Penko AL; Hastilow K; Zimmerman E; Schindler D; Alberts JL
    Health Soc Care Community; 2022 Nov; 30(6):e6122-e6134. PubMed ID: 36214623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Motivators and Barriers to Exercise in Parkinson's Disease.
    Afshari M; Yang A; Bega D
    J Parkinsons Dis; 2017; 7(4):703-711. PubMed ID: 29103050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An increased rate of longitudinal cognitive decline is observed in Parkinson's disease patients with low CSF Aß42 and an APOE ε4 allele.
    Shahid M; Kim J; Leaver K; Hendershott T; Zhu D; Cholerton B; Henderson VW; Tian L; Poston KL
    Neurobiol Dis; 2019 Jul; 127():278-286. PubMed ID: 30826425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Charting the progression of disability in Parkinson disease: study protocol for a prospective longitudinal cohort study.
    Dibble LE; Cavanaugh JT; Earhart GM; Ellis TD; Ford MP; Foreman KB
    BMC Neurol; 2010 Nov; 10():110. PubMed ID: 21047426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Change in Body Mass Index, Unified Parkinson's Disease Rating Scale Scores, and Survival Among Persons With Parkinson Disease: Secondary Analysis of Longitudinal Data From NINDS Exploratory Trials in Parkinson Disease Long-term Study 1.
    Wills AM; Pérez A; Wang J; Su X; Morgan J; Rajan SS; Leehey MA; Pontone GM; Chou KL; Umeh C; Mari Z; Boyd J;
    JAMA Neurol; 2016 Mar; 73(3):321-8. PubMed ID: 26751506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression in the LRRK2-Asssociated Parkinson Disease Population.
    Saunders-Pullman R; Mirelman A; Alcalay RN; Wang C; Ortega RA; Raymond D; Mejia-Santana H; Orbe-Reilly M; Johannes BA; Thaler A; Ozelius L; Orr-Urtreger A; Marder KS; Giladi N; Bressman SB;
    JAMA Neurol; 2018 Mar; 75(3):312-319. PubMed ID: 29309488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkinson's Disease Motor Symptom Progression Slowed with Multisensory Dance Learning over 3-Years: A Preliminary Longitudinal Investigation.
    Bearss KA; DeSouza JFX
    Brain Sci; 2021 Jul; 11(7):. PubMed ID: 34356129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of nordic walking exercise on gait, motor/non-motor symptoms, and serum brain-derived neurotrophic factor in individuals with Parkinson's disease.
    Harro CC; Shoemaker MJ; Coatney CM; Lentine VE; Lieffers LR; Quigley JJ; Rollins SG; Stewart JD; Hall J; Khoo SK
    Front Rehabil Sci; 2022; 3():1010097. PubMed ID: 36311206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.